Merck Group-2026_JPM_Presentation_CEO_website_FINAL_EN.pdf

1、Ready for the Next Wave of Growth1CMD 202444th annual J.P.Morgan Healthcare conferenceMerck Beln Garijo,CEOSan Francisco January 12,2026Strong Cash Generation as Backbone for M&AMaximizing opportunities with active portfolio managementWell positioned in secular growth marketsKey growth drivers:Proce

2、ss Solutions,Rare Diseases&SemisResilient in a rapidly changing environmentMulti-industry setup with diversified geographic footprintMerck GroupReady for the Next Wave of Growth2From:Q3 2025 Roadshow PresentationMerck GroupThree Sectors Focusing on Highly-Innovative End-MarketsLife Science2Diversifi

3、ed industry leaderProcess SolutionsLeading product portfolio for bioprocessing,novel templates,chemicals,and formulation materials serving biopharma customersHealthcareGlobal specialty innovatorElectronicsEcosystem relevant portfolioRare diseasesNew strategic pillar for expansion following SpringWor

4、ks M&A and Pimicotinib in-licensing Semiconductor SolutionsIntegrated innovation leader with one of the strongest portfolios of materials and related equipment and servicesSupplying every industry player.Enabling customers to create more complex,smaller and energy-efficient devicesFootnotes:1)Based

5、on FY 2024,excluding Surface Solutions,divested on 31 July 2025;2)New LS business unit structure with go-live date January 1st,2026Acronym(s):BioM=Bio Monitoring;CDMO=Contract Development and Manufacturing Organization;CTS=Contract Testing Services;DxRM=Diagnostics&Regulated Materials;MG=Myasthenia

6、Gravis;mCRC=metastatic Colorectal Cancer;mUC=metastatic Urothelial Carcinoma;LC=Liquid Crystals;OLED=organic light-emitting diode,AR/VR=Augmented/Virtual Reality;43%41%Sales%of group1Sales%of group1Sales%of group116%Advanced SolutionsDelivering specialized lab products and services for a highly regu